Skip to content

News Health

Health News, Tips, and More

Menu
  • Disclaimer
  • Related Sites
Menu

Tag: HGSI

Nasdaq: HGSI for Multiple Myeloma

Posted on June 14, 2010June 13, 2010 by News Health

Human Genome Sciences, Inc. (Nasdaq: HGSI) announced the results of its randomized Phase 2 trial of mapatumumab (HGS-ETR1) in combination with bortezomib (Velcade) in patients with advanced multiple myeloma. The results showed no difference in disease response or progression-free survival for the combination that included mapatumumab vs. the control group receiving bortezomib alone, and showed… Continue reading

Recent Posts

  • What Consultations in Orthodontics Look Like
  • How to Speed Up Injury Recovery
  • How to Use Botox at Home
  • Understanding Vertebral Fractures
  • What is Comprehensive Healthcare and Why is it Important?
  • Little-Known Facts About Assisted Living Facilities
  • How CBD Bath Products Can Benefit You
  • What Is a Hydrafacial?
  • 6 Tips on How to Get Great Teeth
  • Everything You Need to Know About Hayfever

Archives

August 2022
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
293031  
« Jul    
© 2022 News Health | Powered by Superbs Personal Blog theme